Aravive, Inc. Profile Avatar - Palmy Investing

Aravive, Inc.

Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets…

Biotechnology
US, Houston [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ARAV's Analysis
CIK: 1513818 CUSIP: 03890D108 ISIN: US03890D1081 LEI: - UEI: -
Secondary Listings
ARAV has no secondary listings inside our databases.